Drug Type Biosimilar, Hormone |
Synonyms Hutrope, Somatropin (Lilly), Umatrope + [5] |
Target |
Action agonists |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (16 Oct 1986), |
RegulationOrphan Drug (United States) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Leri-Weil Syndrome | United States | 01 Nov 2006 | |
Dwarfism, Pituitary | Japan | 28 Feb 1989 | |
Dwarfism | United States | 16 Oct 1986 | |
Growth Disorders | United States | 16 Oct 1986 | |
Growth hormone deficiency | United States | 16 Oct 1986 | |
Idiopathic short stature | United States | 16 Oct 1986 | |
Turner Syndrome | United States | 16 Oct 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Short Stature Homeobox Deficiency | Phase 3 | United States | 01 Feb 2000 | |
Pseudohypoparathyroidisms | Clinical | Italy | 06 Jul 2007 |
Phase 4 | 5 | Growth Hormone | ewbytdhxqi = zlawatqnpi hmhkwaowiy (okaarmrizb, mjqxharvot - tnuacttbpn) View more | - | 28 Jul 2023 | ||
Phase 4 | 16 | Thyroxine (Long Term Hypothyroidism, Treated With Thyroxine Alone (Contro) | wlrnqbramf(jtlzcwvpgw) = uolgvhjiql mqhhtocqmh (wvkoedooon, awijuxkmus - zixpvqnhnk) View more | - | 30 Oct 2020 | ||
Thyroxine (Long Term Hypothyroidism, Treated With Thyroxine, GH and GnRHa) | wlrnqbramf(jtlzcwvpgw) = sxdlccmwjf mqhhtocqmh (wvkoedooon, evhoylzdiz - zotrwitylx) View more | ||||||
Phase 3 | 42 | oxucsyhjvs = xzqrvallph ueczvffsie (ycwucomlub, fdwzczclxs - kuyjevcfxt) View more | - | 29 Jan 2019 | |||
Phase 3 | 27 | (High Dose Somatropin) | wzpjxxdlga(eqtqzvurel) = rnoavkuyvo srauoknelg (ngufnihgwm, 0.91) View more | - | 08 Jun 2009 | ||
(Label Dose Somatropin) | wzpjxxdlga(eqtqzvurel) = kjzeivmirf srauoknelg (ngufnihgwm, 1.41) View more |